Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
05 sept. 2023 08h30 HE
|
Avenue Therapeutics
MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
06 sept. 2022 08h20 HE
|
Organovo, Inc.
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate...
Arbutus to Participate in September Investor Conferences
06 sept. 2022 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...
Guardforce AI to Present at the H.C. Wainwright Global Investment Conference on May 24th
19 mai 2022 07h00 HE
|
Guardforce AI Co., Ltd.
NEW YORK, NY, May 19, 2022 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ: GFAI)(NASDAQ: GFAIW), an integrated security solutions provider, today announced...
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
16 mai 2022 07h00 HE
|
ObsEva SA
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company...
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
16 mai 2022 01h00 HE
|
ObsEva SA
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company...
F-star Therapeutics to Participate in Upcoming Investor Conferences
07 janv. 2022 08h00 HE
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...
Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
05 janv. 2022 08h30 HE
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
InMed Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09 sept. 2021 19h18 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare...
F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
09 sept. 2021 09h00 HE
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...